Cerity Partners
RMD icon

Cerity Partners’s ResMed RMD Stock Holding History

Cerity Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.16M Sell
27,453
-189
-0.7% -$47.1K 0.01% 912
2025
Q4 		$6.66M Sell
27,642
-16,610
-38% -$4.25M 0.01% 818
2025
Q3 		$12.1M Sell
44,252
-819
-2% -$224K 0.02% 509
2025
Q2 		$11.6M Buy
45,071
+29,205
+184% +$6.97M 0.02% 487
2025
Q1 		$3.55M Sell
15,866
-723
-4% -$169K 0.01% 864
2024
Q4 		$3.89M Buy
16,589
+2,903
+21% +$699K 0.01% 821
2024
Q3 		$3.34M Buy
13,686
+6,167
+82% +$1.38M 0.01% 868
2024
Q2 		$1.44M Sell
7,519
-1,128
-13% -$229K ﹤0.01% 1068
2024
Q1 		$1.71M Buy
8,647
+6,643
+331% +$1.22M ﹤0.01% 1049
2023
Q4 		$345K Buy
2,004
+419
+26% +$64.4K ﹤0.01% 1445
2023
Q3 		$234K Buy
1,585
+110
+7% +$19.9K ﹤0.01% 1236
2023
Q2 		$322K Sell
1,475
-5
-0.3% -$1.11K ﹤0.01% 1365
2023
Q1 		$324K Buy
1,480
+243
+20% +$52.7K ﹤0.01% 1500
2022
Q4 		$257K Buy
1,237
+8
+0.7% +$1.76K ﹤0.01% 1213
2022
Q3 		$269K Buy
1,229
+114
+10% +$25.9K ﹤0.01% 942
2022
Q2 		$234K Buy
+1,115
New +$237K ﹤0.01% 1019
2022
Q1 		– Sell
-1,857
Closed -$484K – 1079
2021
Q4 		$484K Buy
1,857
+715
+63% +$186K 0.01% 607
2021
Q3 		$301K Sell
1,142
-3
-0.3% -$820 0.01% 562
2021
Q2 		$282K Sell
1,145
-2
-0.2% -$420 0.01% 601
2021
Q1 		$223K Buy
1,147
+193
+20% +$38.7K 0.01% 631
2020
Q4 		$203K Buy
+954
New +$190K 0.01% 599

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cerity Partners's RMD Position: Q1 2026 in Review

Cerity Partners reduced its ResMed (RMD) stake by 0.68% in Q1 2026, selling an estimated $47.1K and leaving 27,453 shares worth $6.16M. The position accounts for 0.01% of the portfolio, ranked #912.

Cerity Partners first reported a position in RMD in Q4 2020 and has held it in 21 quarters since. The position peaked at $12.1M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Cerity Partners held 27,453 shares of ResMed worth $6.16M as of Q1 2026.
  • Cerity Partners sold 189 ResMed shares in Q1 2026, an estimated $47.1K.
  • ResMed made up 0.01% of Cerity Partners's portfolio in Q1 2026, its #912 holding.
  • Cerity Partners first reported a position in ResMed in Q4 2020 and has held it in 21 quarters since.
  • Cerity Partners's ResMed position peaked at $12.1M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.